DNA News and Research

RSS

DNA, or deoxyribonucleic acid, is the hereditary material in humans and almost all other organisms. Nearly every cell in a person’s body has the same DNA. Most DNA is located in the cell nucleus (where it is called nuclear DNA), but a small amount of DNA can also be found in the mitochondria (where it is called mitochondrial DNA or mtDNA).

NHGRI support research to accelerate development of innovative sequencing technologies

GE Global Research, the technology development arm for the General Electric Company (NYSE: GE), today announced that scientists in their Biosciences Lab have been awarded a second round of funding from the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), to continue research that could reduce the cost and time of sequencing of an entire human genome to less than $1,000, in under a day.

9 Oct 2009

Transgenomic adds DFCI's Cold-PCR mutation detection technology to its portfolio

Transgenomic, Inc. (OTC Bulletin Board: TBIO). The company announced today that it has licensed a high-sensitivity mutation detection technology called Cold-PCR from the Dana-Farber Cancer Institute (DFCI), Boston, MA.

9 Oct 2009

Helicos Biosciences awarded a $2.9M NIH grant

Helicos BioSciences Corporation announced today that it is the recipient of an award from the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH).

8 Oct 2009

Emisphere Technologies announces commercial launch of oral Eligen B12

Emisphere Technologies, Inc. today announced that the Company is introducing and launching its first commercially available product, oral Eligen® B12 (100 mcg). Oral Eligen® B12 (100 mcg) has been specifically developed to help improve Vitamin B12 absorption and bioavailability with a patented formulation.

8 Oct 2009

Adnavance Technologies to present its DNA direct detection technology at the AdvaMed 2009

Adnavance Technologies Inc., a developer of direct detection molecular diagnostic tests for medical applications, announced today that Randy White, Ph.D. chief executive officer, will present initial data supporting direct detection of DNA targets in human clinical samples during company presentations.

8 Oct 2009

NIH awards $1.9 million grant to Pacific Biosciences

Pacific Biosciences, a private company developing a disruptive technology platform for real-time detection of biological events at single molecule resolution, today announced that it has received grants totaling more than $1.9 million from the National Institutes of Health (NIH) as part of the American Recovery & Reinvestment Act of 2009 Research and Research Infrastructure “Grand Opportunities” grants program.

8 Oct 2009

Ipsen and Spirogen sign new licensing agreement for development of SJG-136 anticancer agent

Ipsen and Spirogen Ltd. announced today that the parties have entered into a new agreement superseding their 2003 contractual relationship regarding the DNA minor groove binder SJG-136 (now known as SG2000).

8 Oct 2009

Quest Diagnostics' DNA testing for gene variants help improve outcomes for stent recipients

DNA testing for gene variants that can increase the risk of major coronary events in certain patients taking the anti-clotting drug Plavix® (clopidogrel bisulfate) is now being performed by Quest Diagnostics for Scripps Health patients electing to undergo coronary stent procedures.

From Quest Diagnostics 8 Oct 2009

Proteins play vital role in transferring human genetic code from one cell to another

A Florida State University College of Medicine researcher has solved a century-old mystery about proteins that play a vital role in the transfer of the human genetic code from one cell to another. The discovery could lead to finding new ways to help the body fight a variety of diseases, including cancer.

8 Oct 2009

Study discusses possible genetic effects of radiation and cancer drug exposures on future generations

Researchers at the University of Oklahoma Health Sciences Center are helping to lead a massive international study on the possible genetic effects of radiation and cancer drug exposures on future generations.

8 Oct 2009

Cancer Genome Atlas funds study for analysis and interpretation of tumor genetic data

The Cancer Genome Atlas (TCGA) will fund an effort by scientists at The University of Texas M. D. Anderson Cancer Center to siphon buckets of meaningful information from an ocean of data about the aberrant genetics that drive human cancers.

8 Oct 2009

Johns Hopkins researchers identify several genetic links to autism

About 90 percent of autism spectrum disorders have suspected genetic causes but few genes have been identified so far. Now, leading an international team, Johns Hopkins researchers have identified several genetic links to autism, chief among them a variant of semaphorin 5A, whose protein product controls nerve connections in the brain.

8 Oct 2009

BC Cancer Agency scientists find major breakthrough in breast cancer

For the first time in history, BC Cancer Agency scientists in British Columbia, Canada have decoded all of the three billion letters in the DNA sequence of a metastatic lobular breast cancer tumour, a type of breast cancer which accounts for about 10 per cent of all breast cancers, and have found all of the mutations, or "spelling" mistakes that caused the cancer to spread.

8 Oct 2009

Sangamo declares pricing of common stock; grants option to purchase additional 450,000 shares

Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced the pricing of a public offering of 3,000,000 shares of its common stock. The offering is expected to close on or about October 13, 2009, subject to the satisfaction of customary closing conditions.

8 Oct 2009

Researchers identify tumor-suppressing genes to diagnose the phase of laryngeal cancer

Researchers at Henry Ford Hospital have identified tumor-suppressing genes that may provide a more accurate diagnosis of disease stage and survival for laryngeal cancer patients than current standards.

8 Oct 2009

Family and population based approaches sheds new light on the potential roles of common and rare forms of human genetic variation

In one of the first studies of its kind, an international team of researchers has uncovered a single-letter change in the genetic code that is associated with autism. The finding, published in the October 8 issue of the journal Nature, implicates a neuronal gene not previously tied to the disorder and more broadly, underscores a role for common DNA variation.

8 Oct 2009

NCI awards $11.5 million grant to UAB for cervical cancer research

The University of Alabama at Birmingham (UAB) Comprehensive Cancer Center has won an $11.5 million grant from the National Cancer Institute (NCI) to explore groundbreaking cervical cancer research, prevention and treatment.

8 Oct 2009

New apoptosis detection kit for monitoring chromatin condensation

Enzo Biochem, Inc.’s Enzo Life Sciences division today announced the addition of a new apoptosis detection kit for monitoring chromatin condensation to its rapidly expanding CELLestial™ product line for live cell analysis.

7 Oct 2009

NHGRI awards Geospiza a SBIR grant to develop software systems for detecting rare mutations

Geospiza, Inc., the market leading developer of genetic analysis software, today announced the receipt of a Phase I SBIR grant for “Software Systems for Detecting Rare Mutations” from the National Human Genome Research Institute (1R43HG005297-01).

7 Oct 2009

Idera Pharmaceuticals commences phase 1 IMO-2125 clinical trial for chronic HCV infection

Idera Pharmaceuticals, Inc. today announced that patient treatment has been initiated in a phase 1 clinical trial evaluating IMO-2125 in combination with ribavirin in treatment-naive patients with chronic hepatitis C virus (HCV) infection. IMO-2125 is a novel agonist of Toll-like Receptor (TLR) 9.

7 Oct 2009

DNA News and Research

Further Reading

NHGRI support research to accelerate development of innovative sequencing technologies

Transgenomic adds DFCI's Cold-PCR mutation detection technology to its portfolio

Helicos Biosciences awarded a $2.9M NIH grant

Emisphere Technologies announces commercial launch of oral Eligen B12

Adnavance Technologies to present its DNA direct detection technology at the AdvaMed 2009

NIH awards $1.9 million grant to Pacific Biosciences

Ipsen and Spirogen sign new licensing agreement for development of SJG-136 anticancer agent

Quest Diagnostics' DNA testing for gene variants help improve outcomes for stent recipients

Proteins play vital role in transferring human genetic code from one cell to another

Study discusses possible genetic effects of radiation and cancer drug exposures on future generations

Cancer Genome Atlas funds study for analysis and interpretation of tumor genetic data

Johns Hopkins researchers identify several genetic links to autism

BC Cancer Agency scientists find major breakthrough in breast cancer

Sangamo declares pricing of common stock; grants option to purchase additional 450,000 shares

Researchers identify tumor-suppressing genes to diagnose the phase of laryngeal cancer

Family and population based approaches sheds new light on the potential roles of common and rare forms of human genetic variation

NCI awards $11.5 million grant to UAB for cervical cancer research

New apoptosis detection kit for monitoring chromatin condensation

NHGRI awards Geospiza a SBIR grant to develop software systems for detecting rare mutations

Idera Pharmaceuticals commences phase 1 IMO-2125 clinical trial for chronic HCV infection

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News